Diligent Investors, LLC Amgen Inc Transaction History

Diligent Investors, LLC

$372 Million
Q2 2024

A detailed history of Diligent Investors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Diligent Investors, LLC holds 4,890 shares of AMGN stock, worth $1.55 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

4,890

Previous 4,889 0.02%

Holding current value

$1.55 Million

Previous $1.39 Million 9.86%

% of portfolio

0.41%

Previous 0.38%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	BUY	$262.75 - $319.31 $262 - $319	1 Added 0.02%	4,890 $1.53 Million
Q1 2024 May 03, 2024	SELL	$268.87 - $324.56 $20,971 - $25,315	-78 Reduced 1.57%	4,889 $1.39 Million
Q4 2023 Jan 10, 2024	BUY	$255.7 - $288.46 $10,483 - $11,826	41 Added 0.83%	4,967 $1.43 Million
Q3 2023 Nov 03, 2023	BUY	$218.65 - $271.46 $37,170 - $46,148	170 Added 3.57%	4,926 $1.32 Million
Q2 2023 Jul 24, 2023	BUY	$214.27 - $253.37 $642 - $760	3 Added 0.06%	4,756 $1.06 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $94,831 - $115,584	420 Added 9.69%	4,753 $1.15 Million
Q4 2022 Jan 20, 2023	SELL	$229.03 - $291.01 $116,347 - $147,833	-508 Reduced 10.49%	4,333 $0
Q3 2022 Oct 14, 2022	BUY	$224.46 - $253.15 $210,094 - $236,948	936 Added 23.97%	4,841 $1.09 Million
Q2 2022 Jul 13, 2022	SELL	$230.71 - $256.74 $180,876 - $201,284	-784 Reduced 16.72%	3,905 $950,000
Q1 2022 Apr 26, 2022	BUY	$219.27 - $242.57 $3,508 - $3,881	16 Added 0.34%	4,689 $1.13 Million
Q4 2021 Jan 21, 2022	BUY	$198.88 - $227.6 $290,961 - $332,978	1,463 Added 45.58%	4,673 $1.05 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $700 - $777	3 Added 0.09%	3,210 $783,000
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $887 - $1,034	4 Added 0.12%	3,207 $798,000
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $649 - $773	3 Added 0.09%	3,203 $736,000
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $938 - $1,043	4 Added 0.13%	3,200 $813,000
Q2 2020 Jul 09, 2020	BUY	$197.81 - $242.74 $593 - $728	3 Added 0.09%	3,196 $754,000
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $53,943 - $71,543	-296 Reduced 8.48%	3,193 $647,000
Q4 2019 Jan 13, 2020	SELL	$189.21 - $243.2 $42,004 - $53,990	-222 Reduced 5.98%	3,489 $841,000
Q3 2019 Oct 22, 2019	BUY	$174.11 - $208.62 $696 - $834	4 Added 0.11%	3,711 $718,000
Q2 2019 Aug 01, 2019	BUY	$166.7 - $195.41 $6,334 - $7,425	38 Added 1.04%	3,707 $683,000
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $723 - $815	-4 Reduced 0.11%	3,669 $697,000
Q4 2018 Jan 17, 2019	SELL	$178.4 - $208.25 $62,083 - $72,471	-348 Reduced 8.65%	3,673 $715,000
Q3 2018 Oct 26, 2018	BUY	$185.29 - $208.89 $370 - $417	2 Added 0.05%	4,021 $834,000
Q2 2018 Jul 23, 2018	BUY	$166.05 - $186.51 $332 - $373	2 Added 0.05%	4,019 $742,000
Q1 2018 Apr 23, 2018	BUY	$169.43 - $198.0 $12,876 - $15,048	76 Added 1.93%	4,017 $685,000
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $168 - $188	1 Added 0.03%	3,941 $685,000
Q3 2017 Nov 09, 2017	SELL	$167.29 - $191.0 $58,216 - $66,468	-348 Reduced 8.12%	3,940 $735,000
Q2 2017 Aug 11, 2017	BUY	N/A	4,288	4,288 $739,000

Others Institutions Holding AMGN

# of Institutions

3,056

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Diligent Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Diligent Investors, LLC with notifications on news.

Account

Diligent Investors, LLC Amgen Inc Transaction History